Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873963 · ClinicalTrials.gov registry record
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 544
- Enrollment target
NCT01873963: Completed study, sponsored by Wayne State University.
NCT01873963 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 544 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01873963 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 544 participants
- Enrollment target
Study Summary
Cardiomyopathy in children is a serious disease which can result in death, disability, heart transplantation or serious heart rhythm disorders. Doctors know little about the causes of cardiomyopathy but would like to learn more. In fact, up to 50-75% of cases in children have no known cause. For this reason, the purpose of this study is to identify genes that cause cardiomyopathy or that influence how people with cardiomyopathy do over time. These findings could improve disease prevention, surveillance, early management, and prognosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-03-31 |
What the finished NCT01873963 record still lists
NCT01873963 is an observational study that tracks outcomes without assigning an intervention. The registered 544 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01873963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01873963 about?
NCT01873963 is a clinical study titled "Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)". Cardiomyopathy in children is a serious disease which can result in death, disability, heart transplantation or serious heart rhythm disorders. Doctors know little about the causes of cardiomyopathy but would like to learn more. In fact, up to 50-75% of cases in children have no known cause. For thi...
What is the current status of trial NCT01873963?
This trial is currently completed. The enrollment target is 544 participants. The study started on 2013-04. Estimated completion is 2018-03-31.
Who is sponsoring clinical trial NCT01873963?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06118502 · 544 participants · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
- NCT06170437 · 544 participants · NA
Smoke-free Home Study in Subsidized Housing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia